Assessment of Pharmacodynamic Interactions and Toxicological Effects of Vernonia amygydalina –Metformin Co-Administration on Streptozotocin-Induced Diabetic Wistar Rats . http://www.doi.org/10.26538/tjnpr/v6i12.29
Article Sidebar
Main Article Content
Abstract
Studies have shown an increasing use of herbs concurrently with conventional drugs by patients with diabetes mellitus, with the attendant risks of herb-drug interactions. Hence, this study investigated the possible pharmacological interactions, and toxicological consequences of aqueous extracts of Vernonia amygdalina (VA) and metformin co-administered in streptozotocin (STZ)-induced diabetic Wistar rats. Model of type 2 diabetes was induced in Wistar rats by feeding them with high fat diet and a single dose of STZ (60 mg/kg, i.p.). Animals having blood glucose levels > 200 mg/dl after 72 hours were classified as diabetic and were randomly
assigned to one of eleven (11) groups (n=5 rats) to receive VA extract, metformin or combination at various doses. Blood sample was taken for biochemical and haematological tests while Haemoxylin and Eosin (HE) dye was used to assess histological changes. Results showed a non-additive decrease in blood glucose levels in the VA/metformin co-administration compared to VA and metformin alone. The reduction in blood glucose in VA 50 mg/kg, VA/MET 150 mg/kg and VA 100 mg/kg groups ware -51.20%, -53.52% and -59.68%
respectively. There was significant improvement in urea and creatinine levels as well as liver enzymes at all the doses of VA and VA/metformin co-administration. There were no significant histological changes either in the extract or its combination with metformin on the kidney, liver or pancreas. Hence, VA showed a non-additive interaction with metformin to reduce blood glucose levels with no toxicological effects on major organs.
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
References
Fadare J, Olamoyegun M, Gbadegesin BA. Medication adherence and direct treatment cost among diabetes patients attending a tertiary healthcare facility in Ogbomosho, Nigeria. Malawi Med J. (2015); 27(2):65-70.
Gupta RC, Chang D, Nammi S. Bensoussan A, Bilinski K, Roufogalis BD. Interactions between antidiabetic drugs and herbs: an overview of mechanisms of action and clinical implications. Diabetol Metab Syndr (2017); 9:59.
World Health Organization Traditional Medicine Strategy 2002– 2005, Geneva, Switzerland.
Chang HY, Wallis M, Tiralongo E. Use of complementary and alternative medicine among people living with diabetes: literature review. J Adv Nurs. 2007; 58(4):307–19.
Ogbera AO, Dada O, Adeyeye F, Jewo P. Complementary and alternative medicine use in diabetes mellitus. West Afri J Med. 2010; 29:158-62.
Ala OA, Ojo OA, Enikuomehin CA, Ajani GA, Olamoyegun MA, Akinlade AT. Complementary and alternative medicine (CAM) use among patients with type 2 diabetes in Southwestern, Nigeria. West Afr Med J 2020; 3:43-50.
Gupta RC, Chang D, Nammi S, Bensoussan A, Bilinski K, Roufogalis BD. Interactions between antidiabetic drugs and herbs: an overview of mechanisms of action and clinical implications. Diabetol metabolic syndrome. 2017; 9:59.
Lorke, D. A New Approach to Practical Acute Toxicity Testing. Arch of Toxicol. 1983; 53:275-287.
Okoduwa SI, Umar IA, James DB, Inuwa HM. Validation of the antidiabetic effects of Vernonia amygdalina delile leaf fractions in fortified diet-fed streptozotocin-treated rat model of type-2 diabetes. J Diabetol. 2017; 8:74-85.
WHO (2019): Classification of diabetes mellitus, brochure https://www.who.int/publications-detail/classification-ofdiabetes-mellitus
Ghosh MN. Fundamentals of Experimental Pharmacology. 3rd Edition. Calcutta: Hilton and Company. 2005; 184pp.
Kulkarni CP, Bodhankar SL, Ghule AK, Mohan V, Thakurdesai PA. Antidiabetics activity of trigonella foenumgraecum I. seeds extract (ind01) in neonatal streptozotocin-induced (n-stz) rats. Croatian Med J (2012); 41:29-40.
Szkudelski T. The mechanism of alloxan and streptozotocin action in B cells of the rat pancreas. Physiol Res. 2001; 50(6):537-46.
Asase A and Yohonu DT. Ethnobotanical study of herbal medicines for management of diabetes mellitus in dangme west district of Southern Ghana. Inter J Herb Med. 2016; 6:204-209.
Nwanjo HU. Efficacy of aqueous leaf extract of Vernonia amygdalina on plasma lipoprotein and oxidative status in diabetic rat models. Nigerian J Physiol Sci. 2005; 20 (1-2):39-42.
Adiukwu MU, Uzuegbu BD, Okoye CT, Uzor FP, Adibe MO, Amadi VB. Antidiabetic effects of combined aqueous leaf extract of Vernonia amygdalina and metformin in rats. The J Basic and Clin Physiol and Pharmacol. 2010;1(3):197–202.
Atangwho IJ, Ebong PE, Eyong EU, Eteng MU, Obi AU. Effects of Vernonia amygdalina Leaf on kidney function of diabetic rats. Inte J Pharm. 2007; 3:143-148.
Abdulazeez MA, Ibrahim K, Bulus K, Babvoshia HB, Abdullah Y. Effect of combined use of Ocimum gratissimum and Vernonia amygdalina extract on the activity of angiotensin converting enzyme, hypolipidaemic and antioxidant parameters in streptozotocin-induced diabetic rats. Afri J Biochem Res. 2013; 7:165-173.
Zakaria Y, Azlan NZ, Fakhuruddin N, Hassan N, Muhammad H. Phytochemicals and acute oral toxicity studies of the aqueous extract of Vernonia amygdalina from state of Malaysia. The J Med Plants Stud. 2016; 4:1-5.19.
Ebong PE, Atangwho IJ, Eyong EU, Egbung GE. The antidiabetic efficacy of combined extracts from two continental plants: Azadirachta alloxan-induced diabetic rats treated with ethanol extracts and fractions of Naudea lafiloia leaf’. Euro Sci J. 2008; 9(27):203–210.
Momoh J, Akoro SM, Godonu KG. Hypoglycemic and hepatoprotective effects of Vernonia amygdalina (Bitter Leaf) and its effect on some biochemical parameters in alloxan-induced diabetic male albino rats. Sci J Biotechnol. 2014; 194:1-7.
Adeoye AT, Oyagbemi AA, Adedapo AD, Omobowale TO, Ayodele AE, Adedapo AA. Antidiabetic and antioxidant activities of the methanol leaf extract of Vernonia amygdalina in alloxan-induced diabetes in Wistar rats. J Med Plants for Econ Develop. 2017; 1(1):30.
Vasudevan DM and Sreekumari S. Regulation of blood glucose, insulin and diabetes mellitus. Textbook of Biochemistry for Medical students.6th edn. New Delhi: Jaypee Brothers Medical Publishers (P) Ltd. 2011; 285-290pp.
Ugoanyanwu FO, Mgbeje BI, Igile GO, Ebong PE. The flavonoid rich fraction of Vernonia amygdalina Leaf extract reversed diabetes induced hyperglycaemia and pancreatic beta cell damage in albino Wistar rats. World J Pharm and Pharmaceut Sci. 2015; 4(10):1788-1802.
Monach C, Scalbert A, Morand C, Jimenez L. Polyphenols: food sources and bioavailabilty. American J Clin Nutr. 2004; 79:727- 747.
Ylönen K, Saloranta C, Kronberg-Kippilä C, Groop L, Aro A, Virtanen SM. Associations of dietary fiber with glucose metabolism in non-diabetic relatives of subjects with type 2 diabetes. Diabetes care. 2003; 26:1979-1985.
Oli J, Ikeakor I, Onwuamaeze I. Blood glucose responses to common Nigerian foods. Trop and Geograph Med. (1982); 34:317-322.
Martin OW, Matthias M, Christof S, Ayman MA, Barbel O, Hannah V. Cereal Fibre Improves whole-body Insulin Sensitivity in Overweight and Obese women. American Diabetes Association. 2006; 29(4):775-780
Gerich JE. Hypoglycaemia and counter regulation in type 2 diabetes. Lancet. 2000;9;356 (9246):1946-7.
Chumark P, Khunawat P, Sanvarinda Y, Phornchirasilp S, Morales NP, Phivthongngam L, Ratanachamnong P, Srisawat S, Pongrapeeporn KS . The in vitro and ex vivo antioxidant properties, hypolipidaemic and antiatherosclerotic activities of water extract of Moringa oleifera Lam Leaves. J Ethnopharmacol. 2008; 116:439-446.
Oloyede OB. Carbohydrates “All for the love of nutrient. The Seventy-Eight Inaugural Lecture. University of Ilorin. 2005; 14(31).
Gorinstein S, Caspi A, Libman I, Lerner H, Huang D, Feng S, Trakhtenberg S. Grapefruit positively influences serum triglycerides level in the patients suffering from coronary atherosclerosis: studies in vitro and in human. J Agri and Food Chem. 2006; 54(5):1887-1892.